Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H U Simon

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Oncogene|May 23, 2006
Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophilsS Martinelli, G Kostylina, V Niggli, et al.
Allergy|February 9, 2012
Pediatric and adult eosinophilic esophagitis: similarities and differencesA Straumann, S S Aceves, C Blanchard, et al.
The Journal of Clinical Investigation|July 6, 2000
T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitisA Trautmann, M Akdis, D Kleemann, et al.
Allergy|April 18, 2013
In vitro differentiation of near-unlimited numbers of functional mouse basophils using conditional Hoxb8U Gurzeler, T Rabachini, C A Dahinden, et al.
Allergy|February 6, 2013
Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitisA Straumann, S Hoesli, Ch Bussmann, et al.
Current Problems in Dermatology|June 22, 1999
Role of T cells and cytokines in the intrinsic form of atopic dermatitisC A Akdis, M Akdis, D Simon, et al.
The Journal of Investigative Dermatology|October 3, 1999
T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitisC A Akdis, M Akdis, D Simon, et al.
Gut|October 16, 2009
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trialA Straumann, S Conus, P Grzonka, et al.
Pneumologie (Stuttgart, Germany)|February 14, 2002
[Difficult to manage asthma: clinical phenotypes and principles of therapy]G Menz, R Buhl, A Gillissen, et al.
Allergy|January 12, 2008
Important questions in allergy: novel research areasJ Bousquet, T Bieber, W Fokkens, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Oncogene|May 23, 2006
Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophilsS Martinelli, G Kostylina, V Niggli, et al.
Allergy|February 9, 2012
Pediatric and adult eosinophilic esophagitis: similarities and differencesA Straumann, S S Aceves, C Blanchard, et al.
The Journal of Clinical Investigation|July 6, 2000
T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitisA Trautmann, M Akdis, D Kleemann, et al.
Allergy|April 18, 2013
In vitro differentiation of near-unlimited numbers of functional mouse basophils using conditional Hoxb8U Gurzeler, T Rabachini, C A Dahinden, et al.
Allergy|February 6, 2013
Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitisA Straumann, S Hoesli, Ch Bussmann, et al.
Current Problems in Dermatology|June 22, 1999
Role of T cells and cytokines in the intrinsic form of atopic dermatitisC A Akdis, M Akdis, D Simon, et al.
The Journal of Investigative Dermatology|October 3, 1999
T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitisC A Akdis, M Akdis, D Simon, et al.
Gut|October 16, 2009
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trialA Straumann, S Conus, P Grzonka, et al.
Pneumologie (Stuttgart, Germany)|February 14, 2002
[Difficult to manage asthma: clinical phenotypes and principles of therapy]G Menz, R Buhl, A Gillissen, et al.
Allergy|January 12, 2008
Important questions in allergy: novel research areasJ Bousquet, T Bieber, W Fokkens, et al.
Pageof 17